AEON Biopharma (AEON) Total Debt (2021 - 2026)
AEON Biopharma (AEON) posted Total Debt of $34.6 million for Q4 2025, up 102.92% sequentially from $17.1 million in Q3 2025, and up 196.0% YoY from $11.7 million in Q4 2024.
AEON Biopharma (AEON) Total Debt (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Total Debt for 4 years, with the latest figure at $34.6 million in Q4 2025.
- Quarterly Total Debt rose 196.0% year-over-year to $34.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.6 million (up 196.0% YoY) and the FY2025 annual result came in at $34.6 million, up 196.0% from the prior year.
- Total Debt rose to $34.6 million in Q4 2025 per AEON's latest filing, from $17.1 million in the prior quarter.
- Over five years, Total Debt peaked at $34.6 million in Q4 2025 and troughed at $3495.0 in Q2 2021.
- A 4-year average of $12.4 million and a median of $13.3 million in 2024 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 196.0% in 2025, down 12.4% in 2025.
- Over 4 years, Total Debt stood at $3495.0 in 2021, then surged by 661759.8% to $23.1 million in 2022, then slumped by 49.47% to $11.7 million in 2024, then jumped by 196.0% to $34.6 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $34.6 million, $17.1 million, and $15.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | AEON Biopharma | 10.06 Mn | 6.62 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Dec 31, 2025 | 34.60 Mn |
| Sep 30, 2025 | 17.05 Mn |
| Jun 30, 2025 | 15.17 Mn |
| Mar 31, 2025 | 13.32 Mn |
| Dec 31, 2024 | 11.69 Mn |
| Sep 30, 2024 | 15.17 Mn |
| Jun 30, 2024 | 13.29 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Dec 31, 2022 | 23.13 Mn |
| Sep 30, 2021 | 3,495.00 |
| Jun 30, 2021 | 3,495.00 |
| Mar 31, 2021 | 3,817.00 |